Vitamin D and human health: lessons from vitamin D receptor null mice.
暂无分享,去创建一个
C. Mathieu | Hilary F Luderer | R. Bouillon | G. Carmeliet | M. Demay | L. Verlinden | E. van Etten | A. Verstuyf | L. Lieben
[1] A. Ascherio,et al. Vitamin D and multiple sclerosis , 2010, The Lancet Neurology.
[2] R. Berg,et al. A Systematic Review and Meta-analysis , 2010 .
[3] J. Mill. On the G-compactifications of the rational numbers , 2009 .
[4] E. Mellanby. An Experimental Investigation on Rickets , 2009 .
[5] M. Hediger,et al. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. , 2008, Endocrinology.
[6] M. Osanai,et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. , 2008, Molecular biology of the cell.
[7] R. Gallo,et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. , 2008, The Journal of investigative dermatology.
[8] A. Mackay-Sim,et al. Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice , 2008, Behavioural Brain Research.
[9] D. Tishkoff,et al. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.
[10] G. Ning,et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. , 2008, Kidney international.
[11] C. Mathieu,et al. Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor , 2008, Diabetes.
[12] C. Daniel,et al. Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T Cell Profile , 2008, Journal of Pharmacology and Experimental Therapeutics.
[13] C. Cooper,et al. Maternal vitamin D status during pregnancy and child outcomes , 2008, European Journal of Clinical Nutrition.
[14] R. Wilkinson,et al. IFN--and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37 , 2007 .
[15] M. Mohammadi,et al. The parathyroid is a target organ for FGF23 in rats. , 2007, The Journal of clinical investigation.
[16] F. Rahemtulla,et al. Vitamin D receptor deficiency affects dentin maturation in mice. , 2007, Archives of oral biology.
[17] S. Paik,et al. Phenotype of a Calbindin‐D9k Gene Knockout Is Compensated for by the Induction of Other Calcium Transporter Genes in a Mouse Model , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] B. Graubard,et al. Prospective study of serum vitamin D and cancer mortality in the United States. , 2007, Journal of the National Cancer Institute.
[19] K. Badenhoop,et al. CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans , 2007, Diabetes/metabolism research and reviews.
[20] M. Cutolo,et al. Vitamin D in rheumatoid arthritis. , 2007, Autoimmunity reviews.
[21] A. Litonjua,et al. Is vitamin D deficiency to blame for the asthma epidemic? , 2007, The Journal of allergy and clinical immunology.
[22] J. Adams,et al. Vitamin D in Defense of the Human Immune Response , 2007, Annals of the New York Academy of Sciences.
[23] J. Todd,et al. Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes , 2007, Diabetes.
[24] A. Lengeling,et al. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] Sara Gandini,et al. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.
[26] R. Bouillon,et al. Fetal hypervitaminosis D results in neonatal lethality , 2007 .
[27] D. Trump. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators , 2007 .
[28] M. Wjst,et al. Vitamin D serum levels and allergic rhinitis , 2007, Allergy.
[29] Lisa M Bodnar,et al. Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.
[30] M. Fraga,et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. , 2007, Carcinogenesis.
[31] E. Seely. Calciotropic hormones in preeclampsia: a renewal of interest. , 2007, The Journal of clinical endocrinology and metabolism.
[32] R. Pochampally,et al. Histamine Receptor H1 and Dermatopontin: New Downstream Targets of the Vitamin D Receptor , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] C. Abnet,et al. Serum 25(OH)-Vitamin D Concentration and Risk of Esophageal Squamous Dysplasia , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] Alan Bensoussan,et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis , 2007, The Lancet.
[35] E. L. van den Akker,et al. High prevalence of vitamin D deficiency in newborn infants of high-risk mothers , 2007, Archives of Disease in Childhood.
[36] C. Wagner,et al. Mother-child vitamin D deficiency: an international perspective , 2007, Archives of Disease in Childhood.
[37] P. Lipsky,et al. Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.
[38] P. Hartge,et al. Vitamin D and cancer: current dilemmas and future needs. , 2007, Nutrition reviews.
[39] G. Devereux. Early life events in asthma—diet , 2007, Pediatric pulmonology.
[40] E. Giovannucci. Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. , 2007, Nutrition reviews.
[41] A. Menter,et al. Current and future management of psoriasis , 2007, The Lancet.
[42] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[43] W. Willett,et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. , 2007, Journal of the National Cancer Institute.
[44] Robert J Wilkinson,et al. A single dose of vitamin D enhances immunity to mycobacteria. , 2007, American journal of respiratory and critical care medicine.
[45] M. Inoue,et al. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study , 2007, British Journal of Cancer.
[46] J. Reichrath. Vitamin D and the skin: an ancient friend, revisited , 2007, Experimental dermatology.
[47] D. Bikle. What is new in vitamin D: 2006–2007 , 2007, Current opinion in rheumatology.
[48] Glenville Jones. PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Expanding Role for Vitamin D in Chronic Kidney Disease: Importance of Blood 25‐OH‐D Levels and Extra‐Renal 1α‐Hydroxylase in the Classical and Nonclassical Actions of 1α,25‐Dihydroxyvitamin D3 , 2007 .
[49] A. Mitrakou,et al. The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.
[50] K. Robien,et al. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women’s Health Study , 2007, Cancer Causes & Control.
[51] Robert J Wilkinson,et al. IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-371 , 2007, The Journal of Immunology.
[52] C. Mathieu,et al. Vitamin D3 and the immune system: maintaining the balance in health and disease , 2007, Nutrition Research Reviews.
[53] D. Knol,et al. Vitamin D status predicts physical performance and its decline in older persons. , 2007, The Journal of clinical endocrinology and metabolism.
[54] R. Recker,et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.
[55] Bess Dawson-Hughes,et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[56] E. John,et al. Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure , 2007, Cancer Epidemiology Biomarkers & Prevention.
[57] K. Skorija,et al. Vitamin D receptor is essential for normal keratinocyte stem cell function , 2007, Proceedings of the National Academy of Sciences.
[58] W. Willett,et al. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. , 2007, American journal of epidemiology.
[59] L. Cianferotti,et al. VDR‐mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells , 2007, Journal of cellular biochemistry.
[60] E. Inoue,et al. What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. , 2007, Rheumatology.
[61] Xiaoan Ruan,et al. VDR‐mediated gene expression patterns in resting human coronary artery smooth muscle cells , 2007, Journal of cellular biochemistry.
[62] R. Paulson,et al. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. , 2007, Archives of biochemistry and biophysics.
[63] N. Binkley,et al. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. , 2007, Archives of biochemistry and biophysics.
[64] D. Dang,et al. 1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells , 2007, Molecular Cancer Therapeutics.
[65] S. Boonen,et al. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. , 2007, The Journal of clinical endocrinology and metabolism.
[66] J. Fleet,et al. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice , 2007, The Journal of nutrition.
[67] V. Kuchroo,et al. TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.
[68] Y. Bossé,et al. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. , 2007, Physiological genomics.
[69] C. Carlberg,et al. Selective use of multiple vitamin D response elements underlies the 1 α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene , 2007, Nucleic acids research.
[70] A. Mackay-Sim,et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[71] K. Marchal,et al. 1α,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130 , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[72] D. Alberts,et al. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[73] R. Simpson,et al. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[74] Salahuddin Ahmed,et al. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[75] Jun Sun,et al. Involvement of the vitamin D receptor in the regulation of NF-κB activity in fibroblasts , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[76] J. Welsh,et al. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[77] B. Lanske,et al. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[78] R. Mebius. Vitamins in control of lymphocyte migration , 2007, Nature Immunology.
[79] Junliang Pan,et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.
[80] J. Knight,et al. Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[81] A. Litonjua,et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. , 2007, The American journal of clinical nutrition.
[82] E. Giovannucci,et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. , 2007, American journal of preventive medicine.
[83] C. Mathieu,et al. Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[84] J. Adams,et al. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[85] A. Mackay-Sim,et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders , 2007, Proteomics.
[86] J. Michael Gaziano,et al. A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer , 2007, PLoS medicine.
[87] Bing Li,et al. The Role of Chromatin during Transcription , 2007, Cell.
[88] J. Manson,et al. Calcium/Vitamin D Supplementation and Cardiovascular Events , 2007, Circulation.
[89] K. Badenhoop,et al. The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system , 2007, European journal of immunology.
[90] R. Koerfer,et al. Vitamin D and vascular calcification , 2007, Current opinion in lipidology.
[91] J. Ludvigsson,et al. Vitamin D supplementation and diabetes‐related autoimmunity in the ABIS study , 2007, Pediatric diabetes.
[92] Yoko Yamamoto,et al. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. , 2007, Molecular endocrinology.
[93] G. London,et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.
[94] D. Kiel,et al. A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.
[95] M. Biffi,et al. VDR‐dependent regulation of mast cell maturation mediated by 1,25‐dihydroxyvitamin D3 , 2007, Journal of leukocyte biology.
[96] D. Shields,et al. Improved Renal Allograft Survival with Vitamin D Receptor Polymorphism , 2007, Renal failure.
[97] Jennifer Lin,et al. Intakes of calcium and vitamin D and breast cancer risk in women. , 2006, Archives of internal medicine.
[98] M. Hediger,et al. Marked Disturbance of Calcium Homeostasis in Mice With Targeted Disruption of the Trpv6 Calcium Channel Gene , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[99] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine. , 2007, Toxicology and applied pharmacology.
[100] M. Cantorna,et al. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury , 2007, BMC Immunology.
[101] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[102] C. Doglioni,et al. Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.
[103] D. Lacey,et al. Calcification Inhibitors and Wnt Signaling Proteins Are Implicated in Bovine Artery Smooth Muscle Cell Calcification in the Presence of Phosphate and Vitamin D Sterols , 2006, Calcified Tissue International.
[104] M. Nakane,et al. Vitamin D Analogs Modulate the Expression of Plasminogen Activator Inhibitor-1, Thrombospondin-1 and Thrombomodulin in Human Aortic Smooth Muscle Cells , 2006, Journal of Vascular Research.
[105] K. Okawa,et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.
[106] C. Gordon,et al. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease , 2006, Inflammatory bowel diseases.
[107] A. Nangia,et al. Vitamin D receptor found in human sperm. , 2006, Urology.
[108] C. Mathieu,et al. Vitamin D and cancer , 2013, Cell cycle.
[109] M. Razzaque,et al. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. , 2006, The American journal of pathology.
[110] A. Norman,et al. Minireview: vitamin D receptor: new assignments for an already busy receptor. , 2006, Endocrinology.
[111] Wen Xie,et al. International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor , 2006, Pharmacological Reviews.
[112] P. Carmeliet,et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. , 2006, The Journal of clinical investigation.
[113] J. Loscalzo,et al. Vascular Calcification: Pathobiological Mechanisms and Clinical Implications , 2006, Circulation research.
[114] J. Hoenderop,et al. Critical role of the epithelial Ca2+ channel TRPV5 in active Ca2+ reabsorption as revealed by TRPV5/calbindin-D28K knockout mice. , 2006, Journal of the American Society of Nephrology : JASN.
[115] C. Ryan,et al. High dose calcitriol may reduce thrombosis in cancer patients , 2006, British journal of haematology.
[116] L. Nyström,et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.
[117] D. Albanes,et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. , 2006, Cancer research.
[118] Xujing Wang,et al. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. , 2006, American journal of epidemiology.
[119] D. Miao,et al. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. , 2006, Endocrinology.
[120] D. Eyles,et al. Developmental Vitamin D Deficiency Alters MK 801-Induced Hyperlocomotion in the Adult Rat: An Animal Model of Schizophrenia , 2006, Biological Psychiatry.
[121] C. Mathieu,et al. Immune Regulation of 25-Hydroxyvitamin D-1α-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-γ-Mediated Induction , 2006 .
[122] A. Manto,et al. Slight association between type 1 diabetes and "ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. , 2006, Clinical biochemistry.
[123] J. Szivek,et al. Functionally improved bone in calbindin-D28k knockout mice. , 2006, Bone.
[124] M. Weissenboeck,et al. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[125] E. Fernández,et al. Vitamin D receptor polymorphisms and diseases. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[126] M. Law,et al. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. , 2006, Age and ageing.
[127] H. DeLuca,et al. Calbindin D9k knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level , 2006, Proceedings of the National Academy of Sciences.
[128] G. Stein,et al. Chromatin Remodeling and Transcriptional Activity of the Bone-specific Osteocalcin Gene Require CCAAT/Enhancer-binding Protein β-dependent Recruitment of SWI/SNF Activity* , 2006, Journal of Biological Chemistry.
[129] P. Lips,et al. High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands , 2006 .
[130] R. Simpson,et al. Calcitriol modulation of cardiac contractile performance via protein kinase C. , 2006, Journal of molecular and cellular cardiology.
[131] Ravinder J. Singh,et al. C-3 Epimers Can Account for a Significant Proportion of Total Circulating 25-hydroxyvitamin D in Infants, Complicating Accurate Measurement and Interpretation of Vitamin D Status , 2022 .
[132] P. Alard,et al. Deficiency in NOD Antigen-Presenting Cell Function May Be Responsible for Suboptimal CD4+CD25+ T-Cell–Mediated Regulation and Type 1 Diabetes Development in NOD Mice , 2006, Diabetes.
[133] M. Campbell,et al. Vitamin D status and breast cancer risk. , 2006, Anticancer research.
[134] M. Razzaque,et al. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. , 2006, Trends in molecular medicine.
[135] D. Peehl,et al. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway. , 2006, Anticancer research.
[136] A. Tanaka,et al. Vitamin D3 suppresses the androgen‐stimulated growth of mouse mammary carcinoma SC‐3 cells by transcriptional repression of fibroblast growth factor 8 , 2006, Journal of cellular physiology.
[137] R. Kumar,et al. Vitamin D–Resistant Rickets and Type 1 Diabetes in a Child With Compound Heterozygous Mutations of the Vitamin D Receptor (L263R and R391S): Dissociated Responses of the CYP‐24 and rel‐B Promoters to 1,25‐Dihydroxyvitamin D3 , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[138] Takuji Suzuki,et al. DNA microarray analysis of changes in gene expression induced by 1,25-dihydroxyvitamin D3 in human promyelocytic leukemia HL-60 cells. , 2006, Biomedical research.
[139] Sungtae Kim,et al. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. , 2006, Molecular endocrinology.
[140] C. Glass,et al. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. , 2006, Genes & development.
[141] Dino Moras,et al. Ligand binding domain of vitamin D receptors. , 2006, Current topics in medicinal chemistry.
[142] D. Trump,et al. Phase II trial of high‐dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen‐independent prostate cancer , 2006, Cancer.
[143] J. Flier,et al. Complex Role of the Vitamin D Receptor and Its Ligand in Adipogenesis in 3T3-L1 Cells* , 2006, Journal of Biological Chemistry.
[144] M. Wjst,et al. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway , 2006, Respiratory research.
[145] Wei-dong Yu,et al. Calcitriol (1,25-Dihydroxycholecalciferol) Selectively Inhibits Proliferation of Freshly Isolated Tumor-Derived Endothelial Cells and Induces Apoptosis , 2006, Oncology.
[146] D. d'Ambrosio. Regulatory T cells: how do they find their space in the immunological arena? , 2006, Seminars in cancer biology.
[147] M. Razzaque,et al. Premature aging‐like phenotype in fibroblast growth factor 23 null mice is a vitamin D‐mediated process , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[148] Glenville Jones,et al. Promise of vitamin D analogues in the treatment of hyperproliferative conditions , 2006, Molecular Cancer Therapeutics.
[149] Maureen L. Coleman,et al. Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.
[150] Yan Zhu,et al. Vitamin D receptor is required to control gastrointestinal immunity in IL‐10 knockout mice , 2006, Immunology.
[151] J. Manson,et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.
[152] H. Bischoff-Ferrari,et al. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. , 2006, Archives of internal medicine.
[153] John Robbins,et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.
[154] C. Wagner,et al. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. , 2006, Kidney international.
[155] S. Shaftman,et al. Vitamin D deficiency in systemic lupus erythematosus. , 2006, Autoimmunity reviews.
[156] D. Tamandl,et al. Vitamin D3 down‐regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen‐associated molecular patterns , 2006, European journal of immunology.
[157] C. Cooper,et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study , 2006, The Lancet.
[158] S. Segaert,et al. Calcipotriol cream: A review of its use in the management of psoriasis , 2006, The Journal of dermatological treatment.
[159] O. Gedik,et al. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man , 1986, Diabetologia.
[160] C. Garland,et al. Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.
[161] D. Bikle,et al. Hairless suppresses vitamin D receptor transactivation in human keratinocytes. , 2006, Endocrinology.
[162] F. Montorsi,et al. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. , 2006, European urology.
[163] C. Rumende,et al. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. , 2006, Acta medica Indonesiana.
[164] M. Probst-Kepper,et al. 1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon-γ mediated macrophage activation , 2005 .
[165] D. Batlle,et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. , 2005, Kidney international.
[166] M. Haussler,et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[167] B. De Moor,et al. Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3* , 2005, Journal of Biological Chemistry.
[168] R. Kumar,et al. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[169] P. Pozzilli,et al. Low Levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in Patients with Newly Diagnosed Type 1 Diabetes , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[170] J. Hopper,et al. Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial , 2005, Journal of the American Geriatrics Society.
[171] T. Zemunik,et al. FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. , 2005, The Journal of molecular diagnostics : JMD.
[172] T. Shimada,et al. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. , 2005, American journal of physiology. Renal physiology.
[173] H. Weinans,et al. Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. , 2005, Journal of the American Society of Nephrology : JASN.
[174] A. Hofman,et al. Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. , 2005, American journal of human genetics.
[175] D. Trump,et al. Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer , 2005, Clinical Cancer Research.
[176] John H. White,et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. , 2005, Molecular endocrinology.
[177] S. Nicosia,et al. Suppression of Death Receptor-mediated Apoptosis by 1,25-Dihydroxyvitamin D3 Revealed by Microarray Analysis* , 2005, Journal of Biological Chemistry.
[178] F. Clavel-Chapelon,et al. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3N‐EPIC prospective study , 2005, International journal of cancer.
[179] G. Beaudoin,et al. Hairless triggers reactivation of hair growth by promoting Wnt signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[180] J. Welsh,et al. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[181] D. Miao,et al. Exogenous PTH‐Related Protein and PTH Improve Mineral and Skeletal Status in 25‐Hydroxyvitamin D‐1α‐Hydroxylase and PTH Double Knockout Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[182] S. Lewis,et al. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[183] C. Mathieu,et al. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[184] C. Mathieu,et al. Mechanisms for the selective action of Vitamin D analogs , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[185] C. Mathieu,et al. Immune Regulation of 25‐Hydroxyvitamin‐D3‐1α‐Hydroxylase in Human Monocytes , 2005 .
[186] K. Spach,et al. Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1 , 2005, The Journal of Immunology.
[187] P. N. MacDonald,et al. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription. , 2005, Molecular endocrinology.
[188] M. Cantorna,et al. D-hormone and the immune system. , 2005, The Journal of rheumatology. Supplement.
[189] C. Ryan,et al. High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study. , 2005, The Journal of urology.
[190] J. Eisman,et al. Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform. , 2005, Biochemical and biophysical research communications.
[191] G. Rice,et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[192] S. Kato,et al. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. , 2005, The Biochemical journal.
[193] S. Kato,et al. Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23 , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[194] W. Willett,et al. Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[195] R. Savkur,et al. Coactivation of the Human Vitamin D Receptor by the Peroxisome Proliferator-Activated Receptor γ Coactivator-1 α , 2005, Molecular Pharmacology.
[196] S. Nagpal,et al. Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.
[197] L. Adorini,et al. Inhibition of Acute and Chronic Allograft Rejection in Mouse Models by BXL-628, a Nonhypercalcemic Vitamin D Receptor Agonist , 2005, Transplantation.
[198] H. Tenenhouse. Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. , 2005, Annual review of nutrition.
[199] M. Demay,et al. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[200] C. la Vecchia,et al. Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. , 2005, European urology.
[201] M. Nakane,et al. Vitamin D analogs down‐regulate plasminogen activator inhibitor‐1 in human coronary artery smooth muscle cells , 2005, Journal of thrombosis and haemostasis : JTH.
[202] S. Hanauer,et al. Mechanisms of Disease: vitamin D and inflammatory bowel disease , 2005, Nature Clinical Practice Gastroenterology &Hepatology.
[203] C. Kovacs,et al. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. , 2005, American journal of physiology. Endocrinology and metabolism.
[204] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[205] C. Mathieu,et al. Vitamin D and diabetes , 2005, Diabetologia.
[206] D. Eyles,et al. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats , 2005, Behavioural Brain Research.
[207] S. Ingles,et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. , 2005, Cancer research.
[208] D. Miao,et al. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. , 2005, Human molecular genetics.
[209] S. Gery,et al. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. , 2005, Cancer research.
[210] K. White,et al. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. , 2005, Bone.
[211] Toshio Okano,et al. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. , 2005, Carcinogenesis.
[212] L. Airas,et al. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis , 2005, Multiple sclerosis.
[213] L. Nguyen,et al. Alternative Splicing of Vitamin D-24-Hydroxylase , 2005, Journal of Biological Chemistry.
[214] M. Guy,et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. , 2005, European journal of cancer.
[215] J. Kong,et al. Vitamin D receptor is required for dietary calcium-induced repression of calbindin-D9k expression in mice. , 2005, The Journal of nutritional biochemistry.
[216] R. Ziegler,et al. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. , 2005, The American journal of clinical nutrition.
[217] E. Ford,et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.
[218] H. Cross,et al. Vitamin D and calcium deficits predispose for multiple chronic diseases , 2005, European journal of clinical investigation.
[219] K. Skorija,et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. , 2005, Molecular endocrinology.
[220] D. Carnes,et al. Phospholipase A2 activating protein (PLAA) is required for 1α,25(OH)2D3 signaling in growth plate chondrocytes , 2005, Journal of cellular physiology.
[221] C. Mathieu,et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. , 2005, Endocrinology.
[222] A. Mackay-Sim,et al. Developmental Vitamin D3 deficiency alters the adult rat brain , 2005, Brain Research Bulletin.
[223] A. Mackay-Sim,et al. Behavioural characterization of Vitamin D receptor knockout mice , 2005, Behavioural Brain Research.
[224] C. Crescioli,et al. Human bladder as a novel target for vitamin D receptor ligands. , 2005, The Journal of clinical endocrinology and metabolism.
[225] S. Kato,et al. Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. , 2005, American journal of physiology. Cell physiology.
[226] L. Adorini. Intervention in autoimmunity: the potential of vitamin D receptor agonists. , 2005, Cellular immunology.
[227] J. McGrath,et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.
[228] L. Adorini,et al. Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Type I IFN-Mediated Monocyte Differentiation into Dendritic Cells: Impairment of Functional Activities and Chemotaxis1 , 2005, The Journal of Immunology.
[229] R. Vieth,et al. Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy , 2005, Nutrition and cancer.
[230] A. Kalueff,et al. ABNORMAL BEHAVIORAL ORGANIZATION OF GROOMING IN MICE LACKING THE VITAMIN D RECEPTOR GENE , 2005, Journal of neurogenetics.
[231] Sungtae Kim,et al. 1,25‐Dihydroxyvitamin D3 Stimulates Cyclic Vitamin D Receptor/Retinoid X Receptor DNA‐Binding, Co‐activator Recruitment, and Histone Acetylation in Intact Osteoblasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[232] W. Ebstein. Über das Vorkommen rachitischer Skelettveränderungen im Altertum und im Mittelalter , 1908, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.
[233] A. Berdal,et al. CHAPTER 34 – Dento-alveolar Bone Complex and Vitamin D , 2005 .
[234] M. Demay,et al. Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro , 2005, Journal of cellular biochemistry.
[235] S. Kato,et al. Retracted: Ligand‐induced transrepression by VDR through association of WSTF with acetylated histones , 2005, The EMBO journal.
[236] B. Nilius,et al. Calcium absorption across epithelia. , 2005, Physiological reviews.
[237] Guilin Qiao,et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.
[238] Jian Q. Feng,et al. Critical Role of Calbindin-D28k in Calcium Homeostasis Revealed by Mice Lacking Both Vitamin D Receptor and Calbindin-D28k* , 2004, Journal of Biological Chemistry.
[239] Glenville Jones,et al. Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.
[240] J. Welsh. Vitamin D and breast cancer: insights from animal models. , 2004, The American journal of clinical nutrition.
[241] H. DeLuca. Overview of general physiologic features and functions of vitamin D. , 2004, The American journal of clinical nutrition.
[242] M. Cantorna,et al. Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence , 2004, Experimental biology and medicine.
[243] M. Wjst,et al. Infant Vitamin D Supplementation and Allergic Conditions in Adulthood: Northern Finland Birth Cohort 1966 , 2004, Annals of the New York Academy of Sciences.
[244] J. Welsh,et al. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. , 2004, Carcinogenesis.
[245] C. Mathieu,et al. 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. , 2004, Journal of autoimmunity.
[246] H. DeLuca,et al. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties , 2004, Archives of Biochemistry and Biophysics.
[247] J. Brooks,et al. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[248] R. Getzenberg,et al. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells , 2004, Journal of cellular biochemistry.
[249] D. Strachan,et al. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. , 2004, Diabetes.
[250] S. Kato,et al. 1α, 25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer , 2004 .
[251] A. Kalueff,et al. Increased grooming behavior in mice lacking vitamin D receptors , 2004, Physiology & Behavior.
[252] C. Johansen,et al. 1α,25(OH)2D3 regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression , 2004, Archives of Dermatological Research.
[253] F. Khanim,et al. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells , 2004, Oncogene.
[254] J. Welsh,et al. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. , 2004, Molecular endocrinology.
[255] A. August,et al. Vitamin D Receptor-Deficient Mice Fail to Develop Experimental Allergic Asthma1 , 2004, The Journal of Immunology.
[256] S. Hankinson,et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[257] A. Uitterlinden,et al. Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.
[258] John H. White,et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.
[259] U. Zettl,et al. Transcription factors in autoimmune diseases. , 2004, Current pharmaceutical design.
[260] Yoko Yamamoto,et al. Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice* , 2004, Journal of Biological Chemistry.
[261] L. Adorini,et al. A Vitamin D Analog Down-Regulates Proinflammatory Chemokine Production by Pancreatic Islets Inhibiting T Cell Recruitment and Type 1 Diabetes Development1 , 2004, The Journal of Immunology.
[262] T. Doetschman,et al. Targeted Ablation of Plasma Membrane Ca2+-ATPase (PMCA) 1 and 4 Indicates a Major Housekeeping Function for PMCA1 and a Critical Role in Hyperactivated Sperm Motility and Male Fertility for PMCA4* , 2004, Journal of Biological Chemistry.
[263] Sergey Nejentsev,et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. , 2004, Human molecular genetics.
[264] A. Kalueff,et al. Impaired motor performance in mice lacking neurosteroid vitamin D receptors , 2004, Brain Research Bulletin.
[265] Tsuyoshi Kayo,et al. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. , 2004, Physiological genomics.
[266] C. Ohlsson,et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. , 2004, Endocrinology.
[267] P. Tuohimaa,et al. The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth. , 2004, Biochemical and biophysical research communications.
[268] A. Kalueff,et al. Increased anxiety in mice lacking vitamin D receptor gene , 2004, Neuroreport.
[269] D. Bikle. Vitamin D regulated keratinocyte differentiation , 2004, Journal of cellular biochemistry.
[270] K. Kragballe,et al. New vitamin D analogs in psoriasis. , 2004, Current drug targets. Inflammation and allergy.
[271] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[272] J. Brooks,et al. Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays , 2004, The Prostate.
[273] A. Dusso,et al. 1α-Hydroxylase transactivation by γ-interferon in murine macrophages requires enhanced C/EBPβ expression and activation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[274] Hiroyuki Tanaka,et al. Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[275] D. Bikle,et al. Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[276] Guilin Qiao,et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[277] S. Kato,et al. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[278] C. Mathieu,et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[279] R. Mason,et al. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway , 2004, Journal of Steroid Biochemistry and Molecular Biology.
[280] R. Kumar,et al. Gene expression profiles in dendritic cells conditioned by 1α,25-dihydroxyvitamin D3 analog , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[281] Bess Dawson-Hughes,et al. Effect of Vitamin D on falls: a meta-analysis. , 2004, JAMA.
[282] D. Miao,et al. Inactivation of the 25-Hydroxyvitamin D 1α-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis* , 2004, Journal of Biological Chemistry.
[283] F. Watt,et al. Transient activation of β-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours , 2004, Development.
[284] R. Wood,et al. DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. , 2004, Physiological genomics.
[285] R. St-Arnaud,et al. 1alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene. , 2004, American journal of physiology. Renal physiology.
[286] VDR gene polymorphism at exon 2 start codon (FokI) may have influenced Type 1 diabetes mellitus susceptibility in two Spanish populations , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[287] P. Elias,et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. , 2004, The Journal of investigative dermatology.
[288] E. Giovannucci,et al. Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer , 2004, Cancer Causes & Control.
[289] M. Serio,et al. Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. , 2004, European journal of endocrinology.
[290] H. DeLuca,et al. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. , 2004, Biochemistry.
[291] S. Kato,et al. Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. , 2004, American journal of physiology. Renal physiology.
[292] Johan Moan,et al. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.
[293] Y. Takeuchi,et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.
[294] A. Norman,et al. Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[295] C. Mathieu,et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice , 2004, Diabetologia.
[296] W. Willett,et al. Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.
[297] Y. Takeuchi,et al. FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[298] B. De Moor,et al. The Effects of 1α,25‐Dihydroxyvitamin D3 on the Expression of DNA Replication Genes , 2003 .
[299] N. Raghavachari,et al. Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray , 2003, Breast Cancer Research and Treatment.
[300] M. Haussler,et al. Molecular Nature of the Vitamin D Receptor and its Role in Regulation of Gene Expression , 2001, Reviews in Endocrine and Metabolic Disorders.
[301] M. Hakama,et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.
[302] H. Adami,et al. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) , 1998, Cancer Causes & Control.
[303] L. Kolonel,et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) , 1998, Cancer Causes & Control.
[304] D. Albanes,et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men , 1997, Cancer Causes & Control.
[305] C. Hales,et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians , 1995, Diabetologia.
[306] C. Mathieu,et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 , 1994, Diabetologia.
[307] M. Wjst,et al. Infant vitamin D supplementation and allergic conditions in aduldhood , 2004 .
[308] M. Palmer,et al. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. , 2004, Microbial pathogenesis.
[309] S. Kato,et al. Retracted: Transrepression by a liganded nuclear receptor via a bHLH activator through co‐regulator switching , 2004, The EMBO journal.
[310] W. Grant. Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. , 2004, Lupus.
[311] F. Dudbridge,et al. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes , 2004, Genes and Immunity.
[312] G. Brent. Tissue-Specific Actions of Thyroid Hormone: Insights From Animal Models , 2004, Reviews in Endocrine and Metabolic Disorders.
[313] M. Macoritto,et al. Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity , 2004, Biogerontology.
[314] S. Fukumoto,et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[315] Anthony W. Norman,et al. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model , 2004, Nature Reviews Drug Discovery.
[316] J. Cerhan,et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.
[317] Pär Stattin,et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries , 2004, International journal of cancer.
[318] F. Kersten,et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. , 2003, The Journal of clinical investigation.
[319] Timothy R Church,et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. , 2003, Journal of the National Cancer Institute.
[320] K. Fukuda,et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. , 2003, Molecular endocrinology.
[321] J. Welsh,et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. , 2003, Molecular endocrinology.
[322] Marjolein Visser,et al. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. , 2003, The Journal of clinical endocrinology and metabolism.
[323] J. Burleson,et al. Effects of Vitamin D Supplementation on Strength, Physical Function, and Health Perception in Older, Community‐Dwelling Men , 2003, Journal of the American Geriatrics Society.
[324] J. Ilonen,et al. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. , 2003, European journal of endocrinology.
[325] R. Kumar,et al. Vitamin D and its analogs as regulators of immune activation and antigen presentation. , 2003, Annual review of nutrition.
[326] R. Andreesen,et al. Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells , 2003 .
[327] M. Haussler,et al. Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling* , 2003, Journal of Biological Chemistry.
[328] P. Carmeliet,et al. Intestinal Calcium Transporter Genes Are Upregulated by Estrogens and the Reproductive Cycle Through Vitamin D Receptor‐Independent Mechanisms , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[329] J. Verhaeghe,et al. Pregnancy in Mice Lacking the Vitamin D Receptor: Normal Maternal Skeletal Response, But Fetal Hypomineralization Rescued by Maternal Calcium Supplementation , 2003, Pediatric Research.
[330] R. Yolken,et al. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.
[331] T. Ganz. Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.
[332] S. Hwang,et al. Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. , 2003, Life sciences.
[333] M. Cantorna,et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.
[334] M. Wolf,et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. , 2003, The New England journal of medicine.
[335] J. Dancey,et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma , 2003, British Journal of Cancer.
[336] Wei Zheng,et al. Altered gene expression profile in the kidney of vitamin D receptor knockout mice , 2003, Journal of cellular biochemistry.
[337] K. Wagner,et al. 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. , 2003, Experimental eye research.
[338] M. Egorin,et al. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[339] H. Degreef,et al. 1,25‐dihydroxyvitamin D3 inhibits ultraviolet B‐induced apoptosis, Jun kinase activation, and interleukin‐6 production in primary human keratinocytes , 2003, Journal of cellular biochemistry.
[340] Hiromichi Nagasawa,et al. RETRACTED: The Chromatin-Remodeling Complex WINAC Targets a Nuclear Receptor to Promoters and Is Impaired in Williams Syndrome , 2003, Cell.
[341] M. Haussler,et al. Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. , 2003, Endocrinology.
[342] A. Dusso. Vitamin D receptor: mechanisms for vitamin D resistance in renal failure. , 2003, Kidney international. Supplement.
[343] Aristides G. Eliopoulos,et al. Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.
[344] A. Mackay-Sim,et al. Vitamin d3 and brain development , 2003, Neuroscience.
[345] J. Adams,et al. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[346] F. Glorieux,et al. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). , 2003, Bone.
[347] F. Glorieux,et al. Rescue of the Pseudo‐Vitamin D Deficiency Rickets Phenotype of CYP27B1‐Deficient Mice by Treatment With 1,25‐Dihydroxyvitamin D3: Biochemical, Histomorphometric, and Biomechanical Analyses , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[348] C. Mathieu,et al. Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. , 2003, Bone.
[349] Imad Hakim,et al. Modulation of TNF‐α expression in bone marrow macrophages: Involvement of vitamin D response element , 2003, Journal of cellular biochemistry.
[350] E. Wolf,et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[351] Glenville Jones,et al. Vitamin D analogs--drug design based on proteins involved in vitamin D signal transduction. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.
[352] C. Mathieu,et al. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.
[353] P. Thomas,et al. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[354] S. Kato,et al. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. , 2003, The Journal of nutrition.
[355] H. DeLuca,et al. Vitamin D and autoimmune diabetes , 2003, Journal of cellular biochemistry.
[356] P. Malloy,et al. Hereditary 1,25-Dihydroxyvitamin D-resistant rickets. , 1997, Endocrine development.
[357] 遠藤 逸朗. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors , 2003 .
[358] Z. Hochberg. Rickets--past and present. Introduction. , 2003, Endocrine development.
[359] A. Ponsonby,et al. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. , 2002, Toxicology.
[360] T. Meehan,et al. The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ , 2002 .
[361] J. Sundberg,et al. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. , 2002, Carcinogenesis.
[362] M. Worm,et al. 1α,25‐dihydroxyvitamin D3 inhibits anti‐CD40 plus IL‐4‐mediated IgE production in vitro , 2002 .
[363] F. Pattou,et al. 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. , 2002, Endocrinology.
[364] B. Györffy,et al. Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus. , 2002, European journal of endocrinology.
[365] A. Norman,et al. Update on biological actions of 1α,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3 , 2002, Molecular and Cellular Endocrinology.
[366] J. Rhim,et al. Targeted Disruption of the 25-Hydroxyvitamin D3 1α-Hydroxylase Gene in ras-Transformed Keratinocytes Demonstrates That Locally Produced 1α,25-Dihydroxyvitamin D3 Suppresses Growth and Induces Differentiation in an Autocrine Fashion11 Canadian Institutes of Health Research Grant MT10839 (to R.K.). , 2002 .
[367] L. Adorini. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. , 2002, Current opinion in investigational drugs.
[368] J. Verhaeghe,et al. Vitamin D Deficiency in Guinea Pigs: Exacerbation of Bone Phenotype During Pregnancy and Disturbed Fetal Mineralization, with Recovery by 1,25(OH)2D3 Infusion or Dietary Calcium-Phosphate Supplementation , 2002, Calcified Tissue International.
[369] J. Hoenderop,et al. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25‐dihydroxyvitamin D3 in 25hydroxyvitamin D3‐1α‐hydroxylase knockout mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[370] M. Demay,et al. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. , 2002, Endocrinology.
[371] S. Toyokuni,et al. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[372] J. Stanford,et al. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[373] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .
[374] R. Balling,et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. , 2002, Molecular endocrinology.
[375] J. Welsh,et al. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. , 2002, Development.
[376] C. Mathieu,et al. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). , 2002, Diabetes.
[377] R. Bretzel,et al. VDR gene polymorphisms are overrepresented in german patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[378] D. Sharma,et al. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[379] M. Uskoković,et al. A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[380] C. Mathieu,et al. Treatment of autoimmune diabetes recurrence in non‐obese diabetic mice by mouse interferon‐β in combination with an analogue of 1α,25‐dihydroxyvitamin‐D3 , 2002 .
[381] M. Farach-Carson,et al. Microarray detection of gene expression changes induced by 1,25(OH)2D3 and a Ca2+ influx-activating analog in osteoblastic ROS 17/2.8 cells , 2002, Steroids.
[382] Stephen H. D. Jackson,et al. Neuromuscular and Psychomotor Function in Elderly Subjects Who Fall and the Relationship With Vitamin D Status , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[383] D. Miao,et al. Parathyroid hormone is essential for normal fetal bone formation. , 2002, The Journal of clinical investigation.
[384] Chilakamarti V. Ramana,et al. Stat1-Vitamin D Receptor Interactions Antagonize 1,25-Dihydroxyvitamin D Transcriptional Activity and Enhance Stat1-Mediated Transcription , 2002, Molecular and Cellular Biology.
[385] H. Koeffler,et al. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. , 2002, The Journal of clinical investigation.
[386] B. Koeleman,et al. Seasonality of birth in patients with type 1 diabetes , 2002, The Lancet.
[387] C. Mathieu,et al. Seasonality of birth in patients with type 1 diabetes , 2002, The Lancet.
[388] T. Meehan,et al. CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[389] Yulei Jiang,et al. Targeted expression of human vitamin d receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. , 2002, The Journal of investigative dermatology.
[390] C. Mathieu,et al. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. , 2002, Trends in molecular medicine.
[391] François Berger,et al. New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.
[392] H. Gogas,et al. A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer , 2002, British Journal of Cancer.
[393] J. Collins,et al. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). , 2002, American journal of physiology. Cell physiology.
[394] K. Philipson,et al. The Na+-Ca2+ Exchanger Is Essential for the Action of Cardiac Glycosides , 2002, Circulation research.
[395] Neil J. McKenna,et al. Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.
[396] L. Freedman,et al. 1,25-Dihydroxyvitamin D3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.
[397] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[398] J. Todd,et al. The study of CTLA‐4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population , 2002, Journal of cellular and molecular medicine.
[399] A. Berdal,et al. Cross-Talk Between Msx/Dlx Homeobox Genes and Vitamin D During Tooth Mineralization , 2002, Connective tissue research.
[400] D. Sir. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study , 2002 .
[401] L. Mazzucchelli,et al. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. , 2002, Kidney international.
[402] S. Kato,et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. , 2002, The Journal of investigative dermatology.
[403] R. Bouillon,et al. A structural basis for the unique binding features of the human vitamin D-binding protein , 2002, Nature Structural Biology.
[404] M. Uskoković,et al. A 1 , 25-Dihydroxyvitamin D 3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .
[405] M. Demay,et al. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. , 2001, Endocrinology.
[406] U. Gullberg,et al. Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation. , 2001, Experimental hematology.
[407] P. Chambon,et al. Aberrant Growth Plate Development in VDR/RXRγ Double Null Mutant Mice. , 2001, Endocrinology.
[408] R. Sinha,et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[409] H. DeLuca,et al. Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[410] Elina Hyppönen,et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.
[411] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[412] L. Mazzucchelli,et al. 1α,25‐Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts , 2001 .
[413] Huub F. J. Savelkoul,et al. 1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.
[414] P. Carmeliet,et al. Duodenal calcium absorption in vitamin D receptor–knockout mice: Functional and molecular aspects , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[415] B. Dawson-Hughes,et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. , 2001, The American journal of medicine.
[416] V. Laudet,et al. How many nuclear hormone receptors are there in the human genome? , 2001, Trends in genetics : TIG.
[417] M. Stampfer,et al. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. , 2001, The American journal of clinical nutrition.
[418] J. Goverman,et al. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis , 2001, Journal of Neuroimmunology.
[419] A. Christiano,et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. , 2001, The Journal of investigative dermatology.
[420] M. Sitrin,et al. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. , 2001, American journal of physiology. Endocrinology and metabolism.
[421] S. Kato,et al. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. , 2001, Carcinogenesis.
[422] J. Eisman,et al. Novel N-terminal variant of human VDR. , 2001, Molecular endocrinology.
[423] L. Adorini,et al. Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1 , 2001, The Journal of Immunology.
[424] J. Bartek,et al. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. , 2001, Molecular endocrinology.
[425] S. Adami,et al. High prevalence of hypovitaminosis D in female type 2 diabetic population. , 2001, Diabetes care.
[426] A. G. de Herreros,et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling , 2001, The Journal of cell biology.
[427] T. Mcguire,et al. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. , 2001, The Journal of biological chemistry.
[428] E. Fuchs,et al. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. , 2001, Genes & development.
[429] M. Tremblay,et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[430] B. Hoffer,et al. Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats , 2001, Brain Research.
[431] H. DeLuca,et al. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. , 2001, The Journal of nutrition.
[432] R. Kumar,et al. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[433] W. Birchmeier,et al. β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin , 2001, Cell.
[434] D. Moskophidis,et al. Targeted inactivation of the sodium‐calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[435] M. Demay,et al. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. , 2001, The Journal of clinical investigation.
[436] F. Pattou,et al. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. , 2001, The Journal of endocrinology.
[437] H. Minne,et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.
[438] B. Katzenellenbogen,et al. Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.
[439] E. Bajna,et al. 25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis , 2001, Steroids.
[440] A. Howie,et al. Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .
[441] K. Miyamoto,et al. Beneficial Effect of the Active Form of Vitamin D3 against LPS-induced DIC but not against Tissue-factor-induced DIC in Rat Models , 2001, Thrombosis and Haemostasis.
[442] R. Bouillon. Vitamin D: From Photosynthesis, Metabolism, and action to Clinical Applications , 2001 .
[443] F. Glorieux,et al. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. , 2001, Endocrinology.
[444] S. Kato,et al. Dietary phosphorus restriction reverses the impaired bone mineralization in vitamin D receptor knockout mice. , 2001, Endocrinology.
[445] J. Y. Wang,et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. , 2001, Brain research.
[446] A. Howie,et al. Extrarenal Expression of 25-Hydroxyvitamin D 3-1 a-Hydroxylase * , 2001 .
[447] Keiko Yamamoto,et al. 1&agr;,25-Dihydroxyvitamin D3 and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL , 2000, Circulation.
[448] S. Kudoh,et al. Targeted Disruption of Na+/Ca2+ Exchanger Gene Leads to Cardiomyocyte Apoptosis and Defects in Heartbeat* , 2000, The Journal of Biological Chemistry.
[449] M. Cantorna,et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.
[450] C. la Vecchia,et al. Selected micronutrients and colorectal cancer. a case-control study from the canton of Vaud, Switzerland. , 2000, European journal of cancer.
[451] F. Speizer,et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[452] W. Walsh,et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[453] Gina A. Taylor,et al. Involvement of Follicular Stem Cells in Forming Not Only the Follicle but Also the Epidermis , 2000, Cell.
[454] T. Saruta,et al. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. , 2000, Kidney international.
[455] C. Mathieu,et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). , 2000, Diabetes.
[456] L. Freedman,et al. Functional Interactions between the Estrogen Receptor and DRIP205, a Subunit of the Heteromeric DRIP Coactivator Complex* , 2000, The Journal of Biological Chemistry.
[457] A. Lyakhovich,et al. Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells. , 2000, Biochemical and biophysical research communications.
[458] F. Glorieux,et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. , 2000, Endocrinology.
[459] S. Christakos,et al. The role of calbindin and 1,25dihydroxyvitamin D3 in the kidney. , 2000, Current opinion in nephrology and hypertension.
[460] J. Hoenderop,et al. Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. , 2000, Journal of the American Society of Nephrology : JASN.
[461] C. Carlberg,et al. VDR‐Alien: a novel, DNA‐selective vitamin D3 receptor‐corepressor partnership , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[462] M. Demay,et al. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. , 2000, Endocrinology.
[463] H. Koeffler,et al. Induction of apoptosis by vitamin D3 analogue EB1089 in NCI‐H929 myeloma cells via activation of caspase 3 and p38 MAP kinase , 2000, British journal of haematology.
[464] W. Kuo,et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.
[465] T. Y. Chan,et al. Vitamin D Deficiency and Susceptibility to Tuberculosis , 2000, Calcified Tissue International.
[466] C. Mathieu,et al. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. , 2000, Transplantation.
[467] H. DeLuca,et al. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). , 2000, Archives of biochemistry and biophysics.
[468] M. Lazar,et al. The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes , 2000, Molecular and Cellular Biology.
[469] L. Freedman,et al. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. , 2000, Gene.
[470] C. Mathieu,et al. Identification and immune regulation of 25‐hydroxyvitamin D‐1‐α‐hydroxylase in murine macrophages , 2000, Clinical and experimental immunology.
[471] T. Hayashi,et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.
[472] T. Moriwake,et al. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. , 2000, Endocrinology.
[473] G. Hedlund,et al. Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation , 2000, The Journal of Immunology.
[474] M. Baur,et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. , 2000, Diabetes.
[475] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[476] M. Galligan,et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. , 2000, Molecular endocrinology.
[477] R. Wilkinson,et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.
[478] H. DeLuca,et al. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.
[479] G. Martino,et al. Inhibition of Th1 development and treatment of chronic‐relapsing experimental allergic encephalomyelitis by a non‐hypercalcemic analogue of 1,25‐dihydroxyvitamin D3 , 2000, European journal of immunology.
[480] C. Gössl,et al. Seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.
[481] H. Koeffler,et al. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. , 2000, Experimental cell research.
[482] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[483] D. Moras,et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.
[484] C. Tzanno-Martins,et al. Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model. , 1999, Transplantation proceedings.
[485] N. Koszewski,et al. Vitamin D Receptor Interactions with the Rat Parathyroid Hormone Gene: Synergistic Effects Between Two Negative Vitamin D Response Elements , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[486] A. Dlugosz. The Hedgehog and the hair follicle: a growing relationship. , 1999, The Journal of clinical investigation.
[487] M. Traebert,et al. Regulation of small intestinal Na-Pi type IIb cotransporter by dietary phosphate intake. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[488] M. Pollak,et al. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins. , 1999, International journal of oncology.
[489] M. Komine,et al. The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes , 1999, Archives of Dermatological Research.
[490] R. St-Arnaud,et al. Targeted inactivation of vitamin D hydroxylases in mice. , 1999, Bone.
[491] N. Pejnović,et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. , 1999, Clinical and experimental rheumatology.
[492] L. Freedman,et al. A Two-Hit Mechanism for Vitamin D3-Mediated Transcriptional Repression of the Granulocyte-Macrophage Colony-Stimulating Factor Gene: Vitamin D Receptor Competes for DNA Binding with NFAT1 and Stabilizes c-Jun , 1999, Molecular and Cellular Biology.
[493] E. John,et al. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[494] J. Pike,et al. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. , 1999, Endocrine reviews.
[495] Henrik Vorum,et al. An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.
[496] S. Takeda,et al. Stimulation of Osteoclast Formation by 1,25-Dihydroxyvitamin D Requires Its Binding to Vitamin D Receptor (VDR) in Osteoblastic Cells: Studies Using VDR Knockout Mice. , 1999, Endocrinology.
[497] M. Traebert,et al. Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. , 1999, The American journal of physiology.
[498] R. Baron,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society Rescue of the Skeletal Phenotype of Vitamin D Receptor- Ablated Mice in the Setting of Normal Mineral Ion , 2022 .
[499] R. Boland,et al. 1alpha,25-dihydroxy-vitamin-D3-induced store-operated Ca2+ influx in skeletal muscle cells. Modulation by phospholipase c, protein kinase c, and tyrosine kinases. , 1998, The Journal of biological chemistry.
[500] R. Kumar,et al. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. , 1998, Biochemical and biophysical research communications.
[501] E. Kallay,et al. Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression. , 1998, European journal of cancer.
[502] E. Fuchs,et al. De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin , 1998, Cell.
[503] Lars Klareskog,et al. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen‐induced arthritis (CIA) without causing hypercalcaemia , 1998, Clinical and experimental immunology.
[504] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. , 1998, Transplantation.
[505] H. DeLuca,et al. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. , 1998, Transplantation.
[506] B. Wolff,et al. 1α,25‐Dihydroxyvitamin D3 decreases DNA binding of nuclear factor‐κB in human fibroblasts , 1998 .
[507] A. Santoni,et al. Vitamin D3: a transcriptional modulator of the interferon‐γ gene , 1998 .
[508] R. Baron,et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. , 1998, Endocrinology.
[509] R. Bouillon,et al. Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells , 1998, Molecular and Cellular Endocrinology.
[510] T. Koyama,et al. Anticoagulant effects of 1α, 25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes , 1998 .
[511] M. Haussler,et al. Novel nuclear localization signal between the two DNA‐binding zinc fingers in the human vitamin D receptor , 1998, Journal of cellular biochemistry.
[512] R. Coombes,et al. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. , 1998, British Journal of Cancer.
[513] T. Baudino,et al. Isolation and Characterization of a Novel Coactivator Protein, NCoA-62, Involved in Vitamin D-mediated Transcription* , 1998, The Journal of Biological Chemistry.
[514] R J Fletterick,et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. , 1998, Science.
[515] G. Karsenty,et al. Studies of osteocalcin function in dentin formation in rodent teeth. , 1998, European journal of oral sciences.
[516] H. DeLuca,et al. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.
[517] T. Stamey,et al. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) , 1998, The Journal of urology.
[518] A. V. Taylor,et al. Vitamin D replacement in Asians with diabetes may increase insulin resistance. , 1998, Postgraduate medical journal.
[519] C. Mathieu,et al. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. , 1998, Transplantation.
[520] A. Gabr,et al. Vitamin D administration to tuberculous children and its value. , 1998, Bollettino chimico farmaceutico.
[521] R. Bouillon,et al. 1,25‐Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide‐induced apoptosis in non‐obese diabetic (NOD) mice and protects against diabetes , 1998, Clinical and experimental immunology.
[522] L. Freedman,et al. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. , 1998, The Journal of biological chemistry.
[523] M. Álvarez-Dolado,et al. 1,25‐Dihydroxyvitamin D3 inhibits tenascin‐C expression in mammary epithelial cells , 1998, FEBS letters.
[524] R. Hiatt,et al. Prediagnostic serum vitamin D and breast cancer. , 1998, Journal of the National Cancer Institute.
[525] S. Kato,et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. , 1998, The New England journal of medicine.
[526] M. Haussler,et al. The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[527] M. Demay,et al. Analysis of vitamin D-dependent calcium-binding protein messenger ribonucleic acid expression in mice lacking the vitamin D receptor. , 1998, Endocrinology.
[528] J. Park,et al. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. , 1998, Journal of immunology.
[529] S. Kato,et al. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. , 1998, Biochemical and biophysical research communications.
[530] H. DeLuca,et al. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.
[531] M. Cippitelli,et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. , 1998, The Journal of clinical investigation.
[532] M. Lukic,et al. Effector Mechanisms in Low-Dose Streptozotocin-induced Diabetes , 1998, Developmental immunology.
[533] C. Mathieu,et al. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. , 1998, Endocrinology.
[534] T. M. Nguyen,et al. Changes in 1,25-(OH)2D3 synthesis and its receptor expression in spleen cell subpopulations of mice infected with LPBM5 retrovirus. , 1997, Endocrinology.
[535] R. Day,et al. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. , 1997, Urology.
[536] Tadashi Kaname,et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.
[537] P. Froom,et al. Association of calcitriol and blood pressure in normotensive men. , 1997, Hypertension.
[538] C. Mathieu,et al. Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo , 1997, Journal of Neuroimmunology.
[539] A. Zinsmeister,et al. 1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. , 1997, Biochemical and biophysical research communications.
[540] F. Glorieux,et al. The 25‐Hydroxyvitamin D 1‐Alpha‐Hydroxylase Gene Maps to the Pseudovitamin D‐Deficiency Rickets (PDDR) Disease Locus , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[541] S. Kato,et al. 25-Hydroxyvitamin D3 1α-Hydroxylase and Vitamin D Synthesis , 1997 .
[542] K. Watson,et al. Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.
[543] C. Allis,et al. Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.
[544] R. Baron,et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[545] R. Detrano,et al. Ethnic origin and serum levels of 1alpha,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. , 1997, Circulation.
[546] R. Bouillon,et al. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. , 1997, Molecular endocrinology.
[547] K. Colston,et al. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. , 1997, The Journal of endocrinology.
[548] Tatsuya Yoshizawa,et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.
[549] A. Dusso,et al. gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. , 1997, The Journal of clinical endocrinology and metabolism.
[550] D. Godfrey,et al. Flow cytometric study of T cell development in NOD mice reveals a deficiency in αβTCR+CD4-CD8- thymocytes. , 1997 .
[551] C. Mathieu,et al. 1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro. , 1997, Transplantation proceedings.
[552] Y. Taketani,et al. A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[553] J. Rao,et al. Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants. , 1997, Experimental cell research.
[554] S. Samila,et al. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts. , 1997, Transplantation.
[555] O. Garaschuk,et al. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[556] C. Carlberg,et al. Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. , 1997, Biochemical and biophysical research communications.
[557] D. Feldman,et al. Vitamin D in the nervous system: actions and therapeutic potential. , 1997 .
[558] C. Carlberg,et al. Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. , 1997, Biochemical and biophysical research communications.
[559] J. Baron,et al. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[560] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[561] P. Brachet,et al. 1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor , 1996, Neuroreport.
[562] C. Chaumontet,et al. Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-beta production. , 1996, Biochemical pharmacology.
[563] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[564] D. Genser,et al. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. , 1996, Anticancer research.
[565] A. Mackay,et al. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[566] J. Welsh,et al. 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[567] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[568] Y. Sugioka,et al. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. , 1996, Endocrinology.
[569] H. Pols,et al. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089. , 1996, European journal of cancer.
[570] S Majewski,et al. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. , 1996, The journal of investigative dermatology. Symposium proceedings.
[571] M. Stampfer,et al. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[572] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[573] J. Jones,et al. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. , 1996, Cancer research.
[574] R. Kumar,et al. Ontogeny of the 1,25‐dihydroxyvitamin D3 receptor in fetal rat bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[575] S. Manolagas,et al. Erratum: Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3 (Proceedings of the National Academy of Sciences of the United States of America (November 21, 1995) 24 (524)) , 1996 .
[576] S. Manolagas,et al. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[577] L. Freedman,et al. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor , 1995, Molecular and cellular biology.
[578] K. Helzlsouer,et al. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. , 1995, American journal of epidemiology.
[579] R. Bouillon,et al. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3 , 1995, Journal of Neuroimmunology.
[580] L. Lind,et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. , 1995, American journal of hypertension.
[581] H. van den Berg,et al. Serum vitamin D concentrations among elderly people in Europe , 1995, The Lancet.
[582] W. Rhoten,et al. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. , 1995, Endocrinology.
[583] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[584] C. Mathieu,et al. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. , 1995, Endocrinology.
[585] H. Gronemeyer,et al. Transcription factors 3: nuclear receptors. , 1995, Protein profile.
[586] P. Brachet,et al. 1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.
[587] R. Koren,et al. 1,25-Dihydroxyvitamin d3 potentiates the cytotoxic effect of TNF on human breast cancer cells , 1994, Molecular and Cellular Endocrinology.
[588] C. la Vecchia,et al. Selected micronutrient intake and the risk of colorectal cancer. , 1994, British Journal of Cancer.
[589] C. Johnsson,et al. MC 1288 — A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts , 1994, Transplant international : official journal of the European Society for Organ Transplantation.
[590] J. Reichrath,et al. Hair follicle expression of 1,25‐dihydroxyvitamin D3 receptors during the murine hair cycle , 1994, The British journal of dermatology.
[591] K. Bendtzen,et al. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1β-induced inhibition of rat pancreatic islet β-cell function in vitro , 1994 .
[592] A. Boulton,et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. , 1994, Postgraduate medical journal.
[593] M. Riddle,et al. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. , 1994, The American journal of clinical nutrition.
[594] S. Christakos,et al. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. , 1994, Endocrinology.
[595] S. Christakos,et al. DS and Pancreatic ,&Cell Function: Vitamin D Receptors, Gene Expression, and Insulin Secretion* , 1994 .
[596] G. Luisetto,et al. Glucose-Induced Insulin Secretion in Uremia: Role of 1α,25(HO)2-Vitamin D3 , 1994 .
[597] R. Bouillon,et al. Partial prevention of active Heymann nephritis by lα, 25 dihydroxyvitamin D3 , 1993, Clinical and experimental immunology.
[598] J. Peters,et al. 1,25‐Dihydroxyvitamin D3 Exerts Opposing Effects to IL‐4 on MHC Class‐II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes , 1993, Scandinavian journal of immunology.
[599] J. Gaedeke,et al. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[600] E. Corder,et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[601] E. Ritz,et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. , 1993, Blood.
[602] B. Billaudel,et al. Stimulatory effect of 1,25-dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats , 1993, Steroids.
[603] H. DeLuca,et al. Vitamin D deficiency suppresses cell-mediated immunity in vivo. , 1993, Archives of biochemistry and biophysics.
[604] D. Peehl,et al. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. , 1993, Endocrinology.
[605] D. Bikle,et al. Vitamin D, calcium, and epidermal differentiation. , 1993, Endocrine reviews.
[606] Christine Beaulieu,et al. Calcium Is Essential in Normalizing Intolerance to Glucose That Accompanies Vitamin D Depletion In Vivo , 1993, Diabetes.
[607] D. Bikle. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. , 1992, Endocrine reviews.
[608] Z. Hochberg,et al. Calcium therapy for calcitriol-resistant rickets. , 1992, The Journal of pediatrics.
[609] R. Bouillon,et al. 1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice , 1992, Diabetes.
[610] H. DeLuca,et al. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[611] J. Lemire,et al. 1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice , 1992 .
[612] J. Lemire,et al. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. , 1992, Autoimmunity.
[613] A. Mantovani,et al. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. , 2013, Immunology.
[614] J. Lemire,et al. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.
[615] R. Houlgatte,et al. 1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.
[616] E. Burgess,et al. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. , 1990, American journal of hypertension.
[617] C. Garland,et al. Sunlight and breast cancer incidence in the USSR. , 1990, International journal of epidemiology.
[618] A. R. Boland,et al. Influx of extracellular calcium mediates 1,25-dihydroxyvitamin D3-dependent transcaltachia (the rapid stimulation of duodenal Ca2+ transport). , 1990, Endocrinology.
[619] J. F. Young,et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. , 1990, Preventive medicine.
[620] B. Billaudel,et al. Effect of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. , 1990, The American journal of physiology.
[621] K. Matsumoto,et al. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. , 1990, Biochemical and biophysical research communications.
[622] C. Fournier,et al. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. , 1990, Clinical immunology and immunopathology.
[623] R. Gavison,et al. Impaired macrophage activation in vitamin D3 deficiency: differential in vitro effects of 1,25-dihydroxyvitamin D3 on mouse peritoneal macrophage functions. , 1989, Journal of immunology.
[624] J. Wark,et al. The in vitro effect of 1α,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets , 1989 .
[625] J. Haddad,et al. Vitamin D binding protein (Gc-globulin). , 1989, Endocrine reviews.
[626] H. Jörnvall,et al. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. , 1989, The Journal of biological chemistry.
[627] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. , 1989, The American journal of physiology.
[628] L. Lind,et al. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. , 1989, American journal of hypertension.
[629] J. Harmeyer,et al. Placental transport of calcium and phoshorus in pigs , 1989, Journal of perinatal medicine.
[630] Mayumi Sato,et al. Demonstration of 1α,25‐dihydroxyvitamin D3 receptor‐like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation , 1988 .
[631] M. Haussler,et al. Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.
[632] A. Nagler,et al. Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3 , 1987, British journal of haematology.
[633] M. Haussler,et al. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. , 1987, Science.
[634] J. Rousseau,et al. ACUTE TRANSVERSE MYELITIS AS PRESENTING NEUROLOGICAL FEATURE OF LYME DISEASE , 1986, The Lancet.
[635] J. Laragh,et al. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. , 1986, Annals of internal medicine.
[636] R. Boland. Role of vitamin D in skeletal muscle function. , 1986, Endocrine reviews.
[637] A. Norman,et al. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. , 1986, Endocrinology.
[638] C. Ricour,et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. , 1986, The Journal of clinical investigation.
[639] 田中 祥介. Effect of 1,25-dihydroxyvitamin D3 on insulin secretion : direct or mediated? , 1986 .
[640] M. Haussler. Vitamin D receptors: nature and function. , 1986, Annual review of nutrition.
[641] A. Norman,et al. Time course study of insulin secretion after 1,25-dihydroxyvitamin D3 administration. , 1985, Endocrinology.
[642] H. DeLuca,et al. Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. , 1985, Endocrine reviews.
[643] R. Brown,et al. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. , 1985, Tubercle.
[644] R. Brown,et al. Serum concentrations of vitamin D metabolites in untreated tuberculosis. , 1985, Thorax.
[645] E. Barrett-Connor,et al. DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MEN , 1985, The Lancet.
[646] T. Matsui,et al. Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice. , 1985, International archives of allergy and applied immunology.
[647] P. D. de Moor,et al. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. , 1984, Endocrinology.
[648] L. A. Dostal,et al. Effect of vitamin D3 on duodenal calcium absorption in vivo during early development. , 1984, The American journal of physiology.
[649] S. Seino,et al. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. , 1984, Acta endocrinologica.
[650] A. Norman,et al. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. , 1984, The Journal of clinical investigation.
[651] T. Kuroki,et al. Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3 , 1983 .
[652] P. Reitsma,et al. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite , 1983, Nature.
[653] H. DeLuca,et al. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. , 1983, Endocrinology.
[654] L. Orci,et al. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). , 1982, Endocrine reviews.
[655] H. DeLuca,et al. Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.
[656] H. Sakagami,et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[657] H. DeLuca,et al. Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. , 1981, The Journal of biological chemistry.
[658] D. Feldman,et al. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. , 1981, Endocrinology.
[659] G. Grodsky,et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.
[660] H. DeLuca,et al. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. , 1980, The Journal of nutrition.
[661] D. Fraser. Regulation of the metabolism of vitamin D. , 1980, Physiological reviews.
[662] P. D. de Moor,et al. Vitamin D-binding protein (Gc-globulin) binds actin. , 1980, The Journal of biological chemistry.
[663] H. DeLuca,et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.
[664] P. Russell,et al. Prolongation of allograft survival by cyclosporin A. , 1979, Surgical forum.
[665] M. Haussler,et al. Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). , 1977, The New England journal of medicine.
[666] M. Haussler,et al. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). , 1977, The New England journal of medicine.
[667] D. Chick,et al. Study of rickets in Vienna 1919-1922. , 1976, Medical History.
[668] R. Bouillon,et al. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide. , 1975, Annals of internal medicine.
[669] M. Haussler,et al. Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine. , 1975, The Journal of biological chemistry.
[670] H. DeLuca,et al. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. , 1971, Biochemistry.
[671] H. Nowicki,et al. 1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine , 1971, Science.
[672] Dudley H. Williams,et al. Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism , 1971, Nature.
[673] D. Fraser,et al. Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.
[674] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[675] A. Prader,et al. [An unusual form of primary vitamin D-resistant rickets with hypocalcemia and autosomal-dominant hereditary transmission: hereditary pseudo-deficiency rickets]. , 1961, Helvetica paediatrica acta.
[676] A. Windaus,et al. Über die Ultraviolett-Bestrahlung des Dehydro-ergosterins , 1928 .
[677] K. Huldschinsky. Heilung von Rachitis durch künstliche Höhensonne , 1919 .
[678] E. V. Mccollum,et al. THE RELATION OF THE UNIDENTIFIED DIETARY FACTORS, THE FAT-SOLUBLE A, AND WATERSOLUBLE B, OF THE DIET TO THE GROWTHPROMOTING PROPERTIES OF MILK , 1916 .
[679] J. M. Brown. The Etiology of Rickets , 1885, Transactions. Medico-Chirurgical Society of Edinburgh.
[680] A. Embry. Vitamin D Supplementation in the Fight Against Multiple Sclerosis , 2022 .